Kenneth Koury, PhD

Head of Statistics and Modeling
Pfizer

Poster(s):

• (362) Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to Toddlers and Children 6 Months to < 5 Years of Age Who Previously Received Original BNT162b2 as a 3-Dose Primary Series
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (385) Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2
  Thursday, October 12, 2023

  12:15 PM – 1:30 PM US ET

• (1632) Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High Neutralizing Titers in Older Adults
  Friday, October 13, 2023

  12:15 PM – 1:30 PM US ET